Literature DB >> 18985029

Shielding of sleeping beauty DNA transposon-delivered transgene cassettes by heterologous insulators in early embryonal cells.

Trine Dalsgaard1, Brian Moldt, Nynne Sharma, Gernot Wolf, Alexander Schmitz, Finn S Pedersen, Jacob G Mikkelsen.   

Abstract

The Sleeping Beauty (SB) transposon system represents an important alternative to viral integrating vector systems but may, as its viral counterparts, be subject to transcriptional silencing. To investigate shielding of SB-delivered transgene cassettes against transcriptional repression, we establish silencing assays in which SB vector-containing F9 murine teratocarcinoma cell clones are identified by strategies that include or exclude selection for transgene expression. Among clones carrying one or more SB transposon vectors, more than one-third are immediately silenced, and most of the remaining clones move toward silencing during prolonged passage. In line with the lack of an intrinsic ability of SB to resist silencing, we show that the stable transfection rate of SB vectors in F9 cells is significantly improved by flanking the transgene with heterologous 5'-HS4 chicken beta-globin (cHS4) insulators. In approaches based on drug selection and subsequent flow-cytometric detection of transgene expression, clones containing cHS4-insulated vectors are to a much higher degree protected against transcriptional silencing, resulting in long-term expression of the fluorescent marker. Our findings demonstrate that SB vectors, prone for transcriptional silencing by positional effects in F9 cells, are protected by insulators. We believe that insulated SB-derived vectors will become useful tools in transposon-based transgenesis and therapeutic gene transfer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18985029      PMCID: PMC2834987          DOI: 10.1038/mt.2008.224

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  50 in total

1.  Lack of shielding of primer binding site silencer-mediated repression of an internal promoter in a retrovirus vector by the putative insulators scs, BEAD-1, and HS4.

Authors:  C Modin; F S Pedersen; M Duch
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines.

Authors:  E Billy; V Brondani; H Zhang; U Müller; W Filipowicz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

3.  Position-effect protection and enhancer blocking by the chicken beta-globin insulator are separable activities.

Authors:  Félix Recillas-Targa; Michael J Pikaart; Bonnie Burgess-Beusse; Adam C Bell; Michael D Litt; Adam G West; Miklos Gaszner; Gary Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

4.  Topological constraints governing the use of the chicken HS4 chromatin insulator in oncoretrovirus vectors.

Authors:  Evangelia Yannaki; Julie Tubb; Mari Aker; George Stamatoyannopoulos; David W Emery
Journal:  Mol Ther       Date:  2002-05       Impact factor: 11.454

5.  The barrier function of an insulator couples high histone acetylation levels with specific protection of promoter DNA from methylation.

Authors:  Vesco J Mutskov; Catherine M Farrell; Paul A Wade; Alan P Wolffe; Gary Felsenfeld
Journal:  Genes Dev       Date:  2002-06-15       Impact factor: 11.361

6.  Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus.

Authors:  M D Litt; M Simpson; M Gaszner; C D Allis; G Felsenfeld
Journal:  Science       Date:  2001-08-09       Impact factor: 47.728

7.  Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers.

Authors:  C Modin; A H Lund; A Schmitz; M Duch; F S Pedersen
Journal:  Virology       Date:  2000-12-20       Impact factor: 3.616

8.  Gene transfer into genomes of human cells by the sleeping beauty transposon system.

Authors:  Aron M Geurts; Ying Yang; Karl J Clark; Geyi Liu; Zongbin Cui; Adam J Dupuy; Jason B Bell; David A Largaespada; Perry B Hackett
Journal:  Mol Ther       Date:  2003-07       Impact factor: 11.454

9.  Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells.

Authors:  Stephen R Yant; Mark A Kay
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.

Authors:  Jacob Giehm Mikkelsen; Stephen R Yant; Leonard Meuse; Zan Huang; Hui Xu; Mark A Kay
Journal:  Mol Ther       Date:  2003-10       Impact factor: 11.454

View more
  20 in total

1.  Helper-independent piggyBac plasmids for gene delivery approaches: strategies for avoiding potential genotoxic effects.

Authors:  Johann Urschitz; Miyuri Kawasumi; Jesse Owens; Kazuto Morozumi; Hideaki Yamashiro; Ilko Stoytchev; Joel Marh; James A Dee; Kris Kawamoto; Craig J Coates; Joseph M Kaminski; Pawel Pelczar; Ryuzo Yanagimachi; Stefan Moisyadi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

Review 2.  Hybrid lentiviral vectors.

Authors:  Waseem Qasim; Conrad A Vink; Adrian J Thrasher
Journal:  Mol Ther       Date:  2010-04-20       Impact factor: 11.454

3.  Genome-wide mapping of PiggyBac transposon integrations in primary human T cells.

Authors:  Daniel L Galvan; Yozo Nakazawa; Aparna Kaja; Claudia Kettlun; Laurence J N Cooper; Cliona M Rooney; Matthew H Wilson
Journal:  J Immunother       Date:  2009-10       Impact factor: 4.456

4.  PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer.

Authors:  Sai K Saridey; Li Liu; Joseph E Doherty; Aparna Kaja; Daniel L Galvan; Bradley S Fletcher; Matthew H Wilson
Journal:  Mol Ther       Date:  2009-10-06       Impact factor: 11.454

Review 5.  The Sleeping Beauty transposon system: a non-viral vector for gene therapy.

Authors:  Elena L Aronovich; R Scott McIvor; Perry B Hackett
Journal:  Hum Mol Genet       Date:  2011-04-01       Impact factor: 6.150

Review 6.  Sleeping Beauty transposon system for genetic etiological research and gene therapy of cancers.

Authors:  Xiaomei Hou; Yan Du; Yang Deng; Jianfeng Wu; Guangwen Cao
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 7.  Gene therapy for hemoglobinopathies: progress and challenges.

Authors:  Alisa Dong; Stefano Rivella; Laura Breda
Journal:  Transl Res       Date:  2013-01-19       Impact factor: 7.012

8.  Mariner Mos1 transposase optimization by rational mutagenesis.

Authors:  Stéphanie Germon; Nicolas Bouchet; Sophie Casteret; Guillaume Carpentier; Jérémy Adet; Yves Bigot; Corinne Augé-Gouillou
Journal:  Genetica       Date:  2009-06-17       Impact factor: 1.082

Review 9.  Beyond the rat models of human neurodegenerative disorders.

Authors:  Ondrej Bugos; Mangesh Bhide; Norbert Zilka
Journal:  Cell Mol Neurobiol       Date:  2009-03-05       Impact factor: 5.046

10.  Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates.

Authors:  Lajos Mátés; Marinee K L Chuah; Eyayu Belay; Boris Jerchow; Namitha Manoj; Abel Acosta-Sanchez; Dawid P Grzela; Andrea Schmitt; Katja Becker; Janka Matrai; Ling Ma; Ermira Samara-Kuko; Conny Gysemans; Diana Pryputniewicz; Csaba Miskey; Bradley Fletcher; Thierry VandenDriessche; Zoltán Ivics; Zsuzsanna Izsvák
Journal:  Nat Genet       Date:  2009-05-03       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.